Every AI newsletter, investors ask questions on the investor interaction platform: in the future, China’s aging population will continue to accelerate, while the newborn population will increase by a cliff. Population may be a livelihood issue, involving economic, cultural, political and other fields. The state will take strong measures to change the population growth trend, thus affecting China’s economic development, Does your company make a difference in the field of assisted reproduction?
Jiangsu Aoyang Health Industry Co.Ltd(002172) (002172. SZ) said on the investor interaction platform on January 29 that the company’s business has not yet involved the field of assisted reproduction.
